Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We’re flying so low we don’t even register on radar screens. With little to no interest in the stock, we’re right back below $9 after a series of positive PR’s. So disappointing for long term investors after all these years. Just can’t seem to get any sustainable positive momentum. Meanwhile, the market is hitting all time highs.
Weak close action, however at least it closed green and I’m liking the volume!
Showing some strength into the close. Good to see!!
Agreed. Been here too long and have lost my patience. Interestingly enough, I don’t feel negatively toward the job the management teams of any of my other investments. That said, none of them are small cap companies either. I love the products and innovation here....I just don’t feel management is doing the job it could/should.
Dooooowwwn she goesssssss.........Groundhog Day!
Agreed! If management deserves to be rewarded for performing, then they shouldn’t be given bonuses and possibly even be terminated for lack of performance, which has been the case almost every prior year. That’s how you create a top performing culture....Darwinism!
Exactly ????
Chart for CTSO looks phenomenal...??
I wouldn’t have confidence in this management team to run a mailroom. Unfortunately, I’m holding a sizable position (shame on me) and need to slow roll exiting my position. Ideally, I’d like to get out on a pop and forget I ever heard of CTSO. Not too confident I’ll get the pop I’m looking for though. This investment has been a big disappointment.....8 years is being patient in my book.
Did Chan say we would have REMOVE results by the end of the year?
Amazing product. Management’s ability to set expectations and then execute is very poor. They just can’t seem to get out of their own way.....another year over, another disappointment! Although the calendar says Christmas Eve, it feels more like Groundhog Day.
Stopped trials...interesting. I’m almost viewing that as potential good news. This turd could use some positive news so some of us long time holders can move on. Can’t wait to forget about this stock....made the mistake of falling in love with a stock.
@HadToHavit the key is in the number of analysts recommending the stock. In our case, that number is very few. Also, the analysts covering CTSO aren’t top tier firms such as Morgan Stanley, Goldman Sachs, etc. price target has been $15 since 2015 when this moved to the Nasdaq.
Same sh#t different day ??
Approval of what?
Let me clarify....data and ultimately FDA approval is critically important to have a viable business. I’m simply saying that we can’t be one dimensional and only focus on the science/data. That’s why I said that we at least have to focus SOME of our attention towards marketing to institutional and retail investors. Prior to data, investors look at opportunity.....CTSO has a huge opportunity. Companies such as Amazon, Tesla, AOL, etc, etc, etc, have traded at crazy prices prior to earning a single penny. It’s not pumping that I’m suggesting, it’s promoting the potential opportunity we provide to investors willing to get in early on an innovative, and likely disrupting technology. I hope that makes more sense than my previous post.
Because no ones listening. Management has done a poor job marketing this company to institutions and retail investors, therefore there is very little interest in the stock. Management needs to focus at least SOME attention towards raising awareness with institutional and retail investors so they know the company and brand even exists. Until then, it’s same ole same ole up and down, but mostly dead money. This management team is SOLID when it comes to science and getting a start up off to the races. At some point though, you have to say that the skill required to do that is different then the skill set required to run and scale a large organization. When that happens, it’s time to pass the baton to the next team and wait for all the stock you got to run like a cheetah so you can cash out! Just my two cents!
Can’t count on anything with this team running the show.
Maybe. Wouldn’t be the first time.
Been on this train before.....can’t believe it’s happening again.
Nice to see strength into the closing bell!
Well said, sir!
Not to mention, Dr Chan has been saying from the start that we aren’t a COVID play. Our HOME RUN is with Ticagrelor. Not if, but when news drops about that, our technology will be validated and we will be all over investor radar. Just my two cents.
I wouldn’t worry about it too much. Those guys are a bunch of clowns.
Never fails to disappoint. Down, heading into earnings...UH OH. Wonder what someone knows that retail investors don’t?
CTSO likes to behave like the child that LOVES negative attention. It rarely, if ever, fails to disappoint.
I absolutely believe they are making progress with the FDA. What I question, is how effective they are. My suspicion is that they are learning as they go, and learning takes time and costs money. I believe that other, larger, more experienced medical device companies would be much further ahead at this point. Certainly an argument for a partnership agreement. That said, if they are successful going alone, the reward will be greater than if they hadn’t. All risk vs reward...let’s hope they’re successful....only time will tell.
Crickets on this board.
Been a painful few weeks.
Plenty of stories out there. Ever hear the one about Usain Bolt? Fastest man wins the race. Bottom line, things seem to take a long time. No guarantee of success regardless of the speed.
How longs it been since break through designation for Ticagrelor, still no word. Everything seems to move at a snails pace with this company. Meanwhile, SP continues to plummet.
Hopefully we get some news next week and keep this upward momentum going!
Today was quadruple witching. Yesterday was triple.
If only you had waited one more minute to reply. Nasty close!
Can’t wait for FDA news regarding Hemodefend and Ticagrelor trials. Can’t imagine it will be much longer before we hear something.
Would love to hear some news regarding Ticagrelor trial.
The lack of posts says it all. Smh.
Hemo, the company is well positioned financially, I 100% agree. The only area of concern I have, is whether the company it optimizing it’s opportunities. I’m not saying we need a CEO like Elon Musk, but I suspect virtually everyone would agree we would be waayy further ahead in the life cycle of this company if he were our CEO. Maybe another way to say it is that many would grade our current progress to date a C, when what we want is an A performance. Why settle?
Agreed. Been here 8 years and returns would’ve been better and the risk much lower had someone invested in the S&P vs CTSO.
Love your analogy...wish they would’ve left. That said, I may keep a small position, but will sell the rest at $15. I already trimmed 20% in the high 9’s and low $10’s a few weeks ago. Thanks for the laugh...needed that this morning.